首页> 外文OA文献 >A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

【2h】

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

机译：我对先进癌症患者的TRC105（抗结区抗体）的第一阶段研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lee S. Rosen; Herbert I. Hurwitz; Michael K. Wong; Jonathan Goldman; David S. Mendelson; William D. Figg; Shawn Spencer; Bonne J. Adams; Delia Alvarez; Ben K. Seon; Charles P. Theuer; Bryan R. Leigh; Michael S. Gordon;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I first-in-human study of TRC105 (anti-endoglin antibody) in patients with advanced cancer [J] . Clinical cancer research: an official journal of the American Association for Cancer Research . 2012,第17期

机译：晚期癌症患者TRC105（抗Endoglin抗体）的I期首次人体研究
2. A phase I first-in-human study of TRC105 (anti-endoglin antibody) in patients with advanced cancer [J] . Clinical cancer research: an official journal of the American Association for Cancer Research . 2012,第17期

机译：晚期癌症患者TRC105（抗Endoglin抗体）的I期首次人体研究
3. An Open-Label Phase Ib Dose-Escalation Study of TRC105 (Anti-Endoglin Antibody) with Bevacizumab in Patients with Advanced Cancer [J] . Gordon Michael S., Robert Francisco, Matei Daniela, Clinical cancer research: an official journal of the American Association for Cancer Research . 2014,第23期

机译：晚期癌症患者中含贝伐单抗的TRC105（抗Endoglin抗体）的开放标签期Ib剂量递增研究
4. Bioelectrical impedance phase angle as a predictor of survival in patients with advanced cancer. [C] . M. Marra, L. Santarpia, C. Montagnese, World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：生物电阻抗相角可作为晚期癌症患者生存的预测指标。
5. Communication preferences, expectations of benefit, and symptom burdens among advanced cancer patients and partners during patient participation in phase I trials [D] . Hlubocky, Fay J. 2010

机译：患者参加I期试验期间，晚期癌症患者及其伴侣之间的沟通偏好，受益期望以及症状负担
6. A Phase 1 First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer [O] . Lee S. Rosen, Herbert I. Hurwitz, Michael K. Wong, -1

机译：第一阶段先入人TRC105（抗内皮因子抗体）的研究中晚期癌症患者
7. Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer [O] . Pang, HMH, Dellinger, A, Adams, B, 2014

机译：TRC105（抗内皮因子抗体）治疗晚期癌症患者后循环蛋白生物标志物的调节

A Phase I First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅